PTPRC and colitis: Such restoration of TJ integrity was accompanied by a decreased infiltration of CD45+ cells in sGRP78-treated colitis models (43.24% ± 1.40% vs. 63.32% ± 4.45% in DSS-treated mice, p<0.01, Figure 3K).